Who owns Allos Therapeutics?

Key details on Allos Therapeutics (Ticker: ALTH)

Who owns Allos Therapeutics?

Is ALTH a good stock to own? Find out who bought Allos Therapeutics, who sold Allos Therapeutics (ALTH) stock, and who holds a large position in Allos Therapeutics.

Fund Name Number of Shares Share Valuation As Of
Warburg Pincus 26.12M $46.76M June 30, 2012
Wellington Management Company 7.70M $11.39M March 31, 2012
Camber Capital Management 4.70M $6.96M March 31, 2012
HealthCor Management 4.50M $6.66M March 31, 2012
HealthCor Management 4.45M $9.53M June 30, 2011
Vanguard 4.36M $6.45M March 31, 2012
David W. Seeley 3.72M $6.66M June 30, 2012
Duquesne Capital Management 2.80M $12.91M Dec. 31, 2010
Renaissance Technologies 2.45M $4.38M June 30, 2012
Oxford Asset Management 2.31M $4.13M June 30, 2012
Millennium Management 2.27M $3.36M March 31, 2012
Ancora Advisors 1.94M $1.86M Sept. 30, 2012
STATE STREET CORPORATION 1.50M $2.22M March 31, 2012
ARONSON JOHNSON ORTIZ 1.50M $2.68M June 30, 2012
Scopia Management 1.33M $2.38M June 30, 2012
PEAK6 Investments 943200 $1.69M June 30, 2012
T. Rowe Price Associates 863100 $1.54M June 30, 2012
Nomura Holdings 820223 $1.47M June 30, 2012
Altrinsic Global Advisors 772480 $1.38M June 30, 2012
Jacobs Levy Equity Management 619557 $916944 March 31, 2012
Geode Capital Management 605503 $896144 March 31, 2012
Technical Financial Services 572404 $1.02M June 30, 2012
Raging Capital Management 554382 $787222 Dec. 31, 2011
D. E. Shaw & Co 476438 $852824 June 30, 2012
Charles Schwab Investment Management 428963 $643444 March 31, 2012
Frank Russell Company 368941 $560790 March 31, 2012
AQR Capital Management 363200 $650128 June 30, 2012
Spark LP/DE 311800 $461464 March 31, 2012
Loeb Offshore Management 290913 $520734 June 30, 2012

Who sold Allos Therapeutics?

Fund Name Date Sold Number of Shares Sold Share Valuation
Loeb Arbitrage Management Sept. 30, 2011 657766 $1.20M
TIAA-CREF Investment Management Sept. 30, 2011 502814 $925177
Capstone Investment Advisors Sept. 30, 2011 318650 $583129
OrbiMed Advisors June 30, 2011 9.75M $20.86M
Broadfin Capital June 30, 2011 1.11M $2.37M
Credit Suisse AG June 30, 2011 594929 $1.26M
Soros Fund Management June 30, 2011 406000 $868840
WEISS MULTI-STRATEGY ADVISERS June 30, 2011 400000 $856000
Citi June 30, 2011 355295 $760331
Barclays June 30, 2011 340627 $728941
Gerald L. Ray & Associates June 30, 2011 311150 $665861
GOLDMAN SACHS June 30, 2011 290289 $621218
S.A.C. Capital Advisors March 31, 2011 4.59M $14.54M
Columbia Wanger Asset Management March 31, 2011 3.68M $11.67M
Jennison Associates March 31, 2011 2.85M $9.05M
Westfield Capital Management Company March 31, 2011 2.80M $8.86M
Redmile March 31, 2011 1.89M $5.98M
Adage Capital Partners GP March 31, 2011 989100 $3.14M
Ameriprise Financial March 31, 2011 570105 $1.81M
Trellus Management Company March 31, 2011 370800 $1.17M
FMR Dec. 31, 2010 5.84M $26.90M
Sabretooth Capital Management Dec. 31, 2010 1.60M $7.38M
CITADEL ADVISORS Dec. 31, 2010 575494 $2.65M
Commerzbank Aktiengesellschaft Dec. 31, 2010 506365 $2.33M
Diamondback Capital Management Sept. 30, 2010 300000 $1.42M
RHUMBLINE ADVISERS March 31, 2010 346217 $2.57M
Bill & Melinda Gates Foundation Trust March 31, 2009 500000 $3.09M